Zobrazeno 1 - 10 of 166 pro vyhledávání: '"Sadani, S."'
1
Akademický článek
A systematic approach introduced some immune system targets in rectal cancer by considering cell-free DNA methylation in response to radiochemotherapy.
Autor: Bagheri-Hosseinabadi Z; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Eshkevari SMS; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Khalighfard S; Research Center for Development of Advanced Technologies, Tehran, Iran., Alizadeh AM; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: aalizadeh@sina.tums.ac.ir., Khori V; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Amiriani T; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Poorkhani A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Sadani S; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Esmati E; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran., Lashgari M; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran., Mahmoodi M; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran., Hajizadeh MR; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Publikováno v: Cytokine [Cytokine] 2024 Sep; Vol. 181, pp. 156666. Date of Electronic Publication: 2024 Jun 20.
Zobrazit plný text záznamu
2
Akademický článek
Liver Fibrosis and Cirrhosis in Patients with Non-alcoholic Fatty Liver with and without History of Cholecystectomy: A Pilot Study.
Autor: Parsi A; Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Hajiani E; Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Sadani S; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Hashemi SJ; Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Seyedian SS; Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Alimadadi M; Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Ghanbari R; Gene Therapy Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v: Middle East journal of digestive diseases [Middle East J Dig Dis] 2024 Jan; Vol. 16 (1), pp. 34-38. Date of Electronic Publication: 2024 Jan 31.
Zobrazit plný text záznamu
3
Akademický článek
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Autor: Tajaldini M; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Poorkhani A; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Amiriani T; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Amiriani A; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Javid H; Department of Medical Laboratory Sciencess, Catastega Institue of Medical Sciences, Mashhad, Iran., Aref P; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Ahmadi F; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Sadani S; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: somayehsadani@gmail.com., Khori V; Ischemic Disorder Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: vahid.khori@gmail.com.
Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2023 Oct 15; Vol. 957, pp. 175991. Date of Electronic Publication: 2023 Aug 22.
Zobrazit plný text záznamu
4
Akademický článek
Mucocutaneons manifestation in end stage renal disease patients under hemodialysis in 5th Azar hospital in Gorgan, Iran (2009)
Autor: Tajbakhsh R, Dehghan M, Azarhoush R, Sadani S, Kaboutari M, Qorbani M, Samadzadeh S
Publikováno v: مجله دانشگاه علوم پزشکی گرگان, Vol 13, Iss 1, Pp 115-120 (2011)
Background and Objective: Mucocutaneons manifestations are common in hemodialysis patients.The aim of this study was evaluate the prcvalence of cutaneous and mucosal manifestations in end stage renal disease (ESRD) patients who are on the maintenance
Externí odkaz: https://doaj.org/article/4f08122e0e9f44589832e16ca71a0896
Zobrazit plný text záznamu
5
Akademický článek
Homocysteine and high sensitivity C –reactive protein in patients with systemic lupus erythematosus, and their relation with diseases activity and cardiovascular risk factors
Autor: Sedighy S, Sadani S, Rezaii Yazdi Z, Hatef MR, Tavakoli Afshar J, Azarpazhoh MR, Aghai M, Esmaeili H
Publikováno v: مجله دانشگاه علوم پزشکی گرگان, Vol 13, Iss 1, Pp 44-50 (2011)
Background and Objective: Systemic lupus erythematosus (SLE) is an inflammatory multi-system disease with an unknown origin. In patients with lupus disease cardiovascular events is an important cause of mortality and morbidity. This study carried out
Externí odkaz: https://doaj.org/article/faaa52b172f54b13a95659b80431550c
Zobrazit plný text záznamu
6
Akademický článek
Duodenal Web in an Elderly Patient with Abdominal Discomfort and Vomiting: A Rare Case.
Autor: Alimadadi M; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Ghanbari R; Gene Therapy Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Yousefi M; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Sadani S; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.
Publikováno v: Archives of Iranian medicine [Arch Iran Med] 2023 Aug 01; Vol. 26 (8), pp. 455-458. Date of Electronic Publication: 2023 Aug 01.
Zobrazit plný text záznamu
7
Akademický článek
B cells and T cells abnormalities in patients with selective IgA deficiency.
Autor: Bagheri Y; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.; Department of Immunology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran., Moeini Shad T; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Namazi S; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Tofighi Zavareh F; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Azizi G; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Salami F; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Sadani S; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Hosseini A; Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Saeidi M; Department of Immunology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.; Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Pashangzadeh S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran., Delavari S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Mirminachi B; Division of Gastroenterology, Department of Medicine, Duke University, Durham, NC, USA., Rezaei N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Abolhassani H; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran.; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden., Aghamohammadi A; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran. aghamohammadi@sina.tums.ac.ir., Yazdani R; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran. reza_yazdani86@yahoo.com.; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran. reza_yazdani86@yahoo.com.; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden. reza_yazdani86@yahoo.com.; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. reza_yazdani86@yahoo.com.
Publikováno v: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2023 Mar 20; Vol. 19 (1), pp. 23. Date of Electronic Publication: 2023 Mar 20.
Zobrazit plný text záznamu
8
Akademický článek
Breast tumor metastasis following filgrastim administration due to the SDF-1/CXCR4 pathway.
Autor: Khalighfard S; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Research Center on Developing Advanced Technologies, Tehran, Iran., Khori V; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Esmati E; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran., Ahmadi F; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Amiriani T; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Poorkhani A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Sadani S; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Khodayari S; International Center for Personalized Medicine (ICPM), Düsseldorf, Germany., Khodayari H; International Center for Personalized Medicine (ICPM), Düsseldorf, Germany., Kalhori MR; Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran., Keshavarz P; Department of Radiology, Tbilisi State Medical University (TSMU), Tbilisi, Georgia., Alizadeh AM; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. aalizadeh@sina.tums.ac.ir.
Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2023 Jan 06; Vol. 40 (2), pp. 74. Date of Electronic Publication: 2023 Jan 06.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process
Autor: Bergin, P. S., Beghi, E., Sadleir, L. G., Brockington, A., Tripathi, M., Richardson, M. P., Bianchi, E., Srivastava, K., Jayabal, J., Legros, B., Ossemann, M., Mcgrath, N., Verrotti, A., Tan, H. J., Beretta, S., Frith, R., Iniesta, I., Whitham, E., Wanigasinghe, J., Ezeala-Adikaibe, B., Striano, P., Rosemergy, I., Walker, E. B., Alkhidze, M., Rodriguez-Leyva, I., Ramirez Gonzalez, J. A., D'Souza, W. J., Calle, A., Palacios, C., Cairns, A., Carney, P., Craig, D., Gill, D., Gupta, S., Lander, C., Laue-Gizzi, H., Hitchens, N., Kiley, M., Lawn, N., Reyneke, E., Riney, K., Tan, M., Thieban, M., Wong, C., van Rijckevorsel, G., Ferrari Strang, A. G., Gifoni, A., Helio, L., Monnerat, B., Brna, P., Donner, E., Jacques, S., Jette, N., Mclachlan, R., Mohamed, I., Tran, T. P. Y., Bo, X., Fan, S., Guang, Y., Li, M., Wang, K., Zhang, S., Ladino, L., Christensen, J., Kӧlmel, M. S., Nikanorova, M., Uusitalo, A., Vieira, P., Auvin, S., Ediberidze, T., Gogatishvili, N., Jishkariani, T., Dennig, D., Grimmer, A., Michaelis, R., Schubert-Bast, S., Stephani, C., Stodieck, S., Vollbrandt, M., Zellner, A., Zafeiriou, D., Fogarasi, A., Halasz, P., Chaurasia, R. N., Jain, S., Nair, R., Passi, P., Rajadhyaksha, S., Sattaluri, S. J., Shah, H., Udani, V., Costello, D., Aguglia, U., Bartocci, A., Benna, P., Ferlazzo, E., Laino, D., Spalice, A., Zanchi, C., Ali, A., Lim, K. S., Ramirez, A., Anderson, N., Barber, A., Cariga, P., Cleland, J., Child, N., Davis, S., Dayal, V., Dickson, C., Doran, J., Duncan, R., Giri, P., Herd, M., Hutchinson, D., Jones, B., Kao, J., Kilfoyle, D., Mottershead, J., Muir, C., Nolan, M., Pereira, J., Ranta, A., Sadani, S., Simpson, M., Spooner, C., Timmings, P., Walker, E., Wei, D., Willoughby, E., Wong, E., Wu, T., Olusola, T., Mahmud, H., Mogul, Z., Espinoza, J., Vizarreta, J. H., Baeta, E. M., Teotonio, R., Jocic-Jakubi, B., Lukic, S., Korosec, M., Zgur, T., Eguilaz, M. G., Asztely, F., Sithinamsuwan, P., Anderson, J., Auce, P., Desurkar, A., Hamandi, K., Kelso, A., Sanchez, V., Sidra, A., Smith, P., Wehner, T., Winston, G., Andrade, E., Bensalem-Owen, M., Boudreau, M., Caller, T., Chapman, K., Chari, G., Davis, K., Droker, B., El-Hagrassy, M., Eliashiv, D., Eze, C., Heck, C., Kabir, A., Kolesnik, D., Lam, A., Lopez, J., Maamoon, T., Cohen, J. M., Maganti, R., Nwankwo, C., Park, K., Proteasa, S., Sandok, E., Seinfield, S., Toub, J., Wirrell, E., Arbildi, M., Thien, T. T.
Publikováno v: Christensen, J & EpiNet Study Group 2017, ' EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process ', Epilepsia open, vol. 2, no. 1, pp. 20-31 . https://doi.org/10.1002/epi4.12033
Epilepsia Open, Vol. 2, no.1, p. 20-31 (2017)
Bergin, P, Beghi, E, Sadleir, L, Brockington, A, Manjari, T & Richardson, M P 2017, ' EpiNet as a way of involving more physicians and patients in epilepsy research : Validation study and accreditation process ', Epilepsia Open, vol. 2, no. 1, pp. 20-31 . https://doi.org/10.1002/epi4.12033
Epilepsia Open
Objective\ud \ud EpiNet was established to encourage epilepsy research. EpiNet is used for multicenter cohort studies and investigator‐led trials. Physicians must be accredited to recruit patients into trials. Here, we describe the accreditation pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e314bf47e059c4a092d058f95f8d43ff
https://doi.org/10.1002/epi4.12033
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje